Table 3 PRP type and injection characteristics
Study | Leukocyte-poor/rich PRP | Volume (ml) | Activating agent | Applied site |
|---|---|---|---|---|
Castricini et al. 2011 [25] | Leukocyte-rich PRP | NR | Not report | Bone-tendon interface |
Randelli et al. 2011 [31] | Leukocyte-rich PRP | 6 | Calcium chloride | Bone-tendon interface and subacromial space |
Gumina et al. 2012 [27] | Leukocyte-rich PRP | 5.2 | Calcium gluconate | Bone-tendon interface |
Weber et al. 2012 [35] | Leukocyte-poor PRP | 1 | Calcium | Bone-tendon interface |
Jo et al. 2013 [28] | Leukocyte-poor PRP | 9 | Calcium gluconate | Bone-tendon interface |
Ruiz-Moneo et al. 2013 [33] | Leukocyte-poor PRP | 1 | Calcium chloride | Bone-tendon interface |
Malavolta et al. 2014 [30] | Leukocyte-poor PRP | 10 | Calcium chloride | Bone-tendon interface |
Sánchez Márquez et al. 2011 [34] | Leukocyte-poor PRP | 7 | Not report | Bone-tendon interface |
Rodeo et al. 2012 [32] | Leukocyte-poor PRP | 9 | Calcium chloride | Bone-tendon interface |
Flury et al. 2016 [26] | Leukocyte-poor PRP | 4 | Not report | Bone-tendon interface |
Holtby et al. 2016 [9] | Leukocyte-poor PRP | 7 | Not report | Bone-tendon interface |
Pandey et al. 2016 [10] | Leukocyte-poor PRP | 8 | Calcium chloride | Bone-tendon interface |
Jo et al. 2015 [29] | Leukocyte-poor PRP | 9 | Calcium gluconate | Bone-tendon interface |